Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL>CD30+ * > TREAT.: > Co: USA. S. BrentuxiMAb Vedotin> > (*) EU Approval Date: 2018. 01.22

---

(*) EU Approval Date: 2018. 01.22's products
This section has no products